Skip to main content

Molecules & compounds

Articles  —  27 April Apr 2026

Optimizing AAV gene therapy: Preclinical insights on antibody prevalence in cynomolgus macaques

Read More about Optimizing AAV gene therapy: Preclinical insights on antibody prevalence in cynomolgus macaques
Articles  —  17 April Apr 2026

Labcorp China BioA Lab passes U.S. FDA unannounced inspection with Zero Observations

Read More about Labcorp China BioA Lab passes U.S. FDA unannounced inspection with Zero Observations
Articles  —  29 September Sep 2025

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

Read More about Navigating complexities in ADC development with specialized global laboratory support and scientific expertise
Articles  —  12 November Nov 2024

Bridging the Gap: Enabling Equal Access to Biomarker Cancer Testing and Clinical Trials for Black Patients

Read More about Bridging the Gap: Enabling Equal Access to Biomarker Cancer Testing and Clinical Trials for Black Patients
Articles  —  7 October Oct 2024

Accelerating CAR T-cell therapy clinical trial timelines with comprehensive biomarker-driven strategies

Read More about Accelerating CAR T-cell therapy clinical trial timelines with comprehensive biomarker-driven strategies
Articles  —  1 July Jul 2024

Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism

Read More about Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism
Articles  —  14 May May 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Read More about Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)
Articles  —  8 April Apr 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Read More about Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials
Articles  —  4 January Jan 2024

IND-Enabling programs for adoptive cell therapies

Read More about IND-Enabling programs for adoptive cell therapies
Articles  —  6 December Dec 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Read More about Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Articles  —  6 December Dec 2023

Antibody reagents for your host cell protein assay: Experience counts

Read More about Antibody reagents for your host cell protein assay: Experience counts
Articles  —  6 December Dec 2023

Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management

Read More about Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management
Articles  —  16 November Nov 2023

Cell and gene therapy answers: Assessing the critical quality attributes, challenges and importance of CMC

Read More about Cell and gene therapy answers: Assessing the critical quality attributes, challenges and importance of CMC
Articles  —  19 July Jul 2023

Top considerations for developing a biomarker solution and CDx strategy

Read More about Top considerations for developing a biomarker solution and CDx strategy
Articles  —  27 January Jan 2023

Biomarker Q&A: The power of precision medicine for kidney disease

Read More about Biomarker Q&A: The power of precision medicine for kidney disease
Articles  —  17 October Oct 2022

Exploring metastatic breast cancer immunotherapies: Are ADCs and ICIs the answer?

Read More about Exploring metastatic breast cancer immunotherapies: Are ADCs and ICIs the answer?
Articles  —  7 June Jun 2021

The COVID-19 road to recovery: coordinating clinical trial testing and central lab solutions

Read More about The COVID-19 road to recovery: coordinating clinical trial testing and central lab solutions